Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
8-chlorodibenz[b,f][1,4]oxazepin-10(11H)carbonyl chloride → 8-chlorodibenz[b,f][1,4]oxazepine-10(11H)carboxylic acid
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | 8-chlorodibenz[b,f][1,4]oxazepin-10(11H)carbonyl chloride | HCID 14975983 | — |
| 반응물 | N-(methylsulfonyl)-L-phenylalanine, hydrazide | HCID 131718326 | — |
| 생성물 | 8-chlorodibenz[b,f][1,4]oxazepine-10(11H)carboxylic acid | HCID 21983467 | — |
반응 단계
8-chlorodibenz[b,f][1,4]oxazepine-10(11H)-carboxylic acid, 2,[2-[(methylsulfonyl)amino]-1-oxo-3-phenyl]hydrazide (15) was prepared in the manner described above in Example 5 on a 0.51 mmol scale starting with N-(methylsulfonyl)-L-phenylalanine, hydrazide (14), prepared as described above in Example 14, and 8-chlorodibenz[b,f][1,4]-oxazepine-10(11H)-carbonyl chloride (2), prepared as described above in Example 2, to yield 0.11 g (42%) of product.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US05393747 |
| 출처 데이터셋 | uspto-grants-1995_02 |
| ORD ID | ord-3b32e8c689a04fcb9c08536b5c1c1120 |
| 출처 메모 | uspto-grants-1995_02 |